The Food and Drug Administration complete response review indicates that patients having a history of cerebrovascular disease (cerebrovascular, carotid artery
The study included 92 patients from 12 stroke centers in the U
Inspired by his practicum experience at a rehabilitation hospital during his B
Methods: We conducted a systematic review and study-level meta-analyses of randomized controlled trials comparing outcomes of early initiation of short-term DAPT
Both antiplatelet agents (APs) and anticoagulants (ACs) are used to reduce stroke risk, but whether 1 treatment
4%; In the CURE study Plavix + aspirin had a lower rate of CV death, MI or stroke in the first year of treatment
Only one study compared cilostazol to clopidogrel and both groups also received aspirin
Previous clinical trial, CAPRIE, is the only trial which directly comparing the efficacy of aspirin and clopidogrel in patients at risk of ischemic events
AAASPS indicates African American Antiplatelet Stroke Prevention Study; ASCET, Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial; CABG, coronary artery bypass grafting; CADET, Clopidogrel and Aspirin: Determination of the Effects on
Clopidogrel oral tablet is a prescription medication used to prevent heart attack or stroke
Furthermore, stroke patients on clopidogrel had significantly higher mortality rates than those of patients on aspirin (HR=1
In our study of a selected population with moderate-to-high-risk acute coronary syndromes, on average, for every 1000 patients treated with prasugrel as compared with clopidogrel at the doses Antiplatelet therapies are effective for prevention of secondary stroke and can be tailored to individual patient needs
6 One study reported that treatment with clopidogrel after TIA or ischemic stroke did not prevent progression of A regimen of clopidogrel plus apixaban, at the dose labeled for stroke prevention, without aspirin was not associated with excess adverse events and appeared to be effective in this high-risk Mean follow-up was 3
11 Plavix is used to help prevent heart attack and stroke
This analysis supports the further study of antiplatelet loading in patients ineligible for thrombolytics or endovascular procedures
For patients with non–ST-segment elevation ACS (unstable angina [UA]/non–ST-elevation myocardial infarction [NSTEMI]), Plavix has been shown to reduce the rate of myocardial infarction (MI) and stroke